Amyloid-β and Tau The Trigger and Bullet in Alzheimer Disease Pathogenesis

被引:1753
作者
Bloom, George S. [1 ,2 ]
机构
[1] Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA
[2] Univ Virginia, Dept Cell Biol, Charlottesville, VA 22904 USA
基金
美国国家卫生研究院;
关键词
ENDOGENOUS TAU; OLIGOMERS; PROTEIN; PROPAGATION; MECHANISMS; ANTIBODIES; PATHOLOGY; APP;
D O I
10.1001/jamaneurol.2013.5847
中图分类号
R74 [神经病学与精神病学];
学科分类号
100204 [神经病学];
摘要
The defining features of Alzheimer disease (AD) include conspicuous changes in both brain histology and behavior. The AD brain is characterized microscopically by the combined presence of 2 classes of abnormal structures, extracellular amyloid plaques and intraneuronal neurofibrillary tangles, both of which comprise highly insoluble, densely packed filaments. The soluble building blocks of these structures are amyloid-beta (A beta) peptides for plaques and tau for tangles. Amyloid-beta peptides are proteolytic fragments of the transmembrane amyloid precursor protein, whereas tau is a brain-specific, axon-enriched microtubule-associated protein. The behavioral symptoms of AD correlate with the accumulation of plaques and tangles, and they are a direct consequence of the damage and destruction of synapses that mediate memory and cognition. Synapse loss can be caused by the failure of live neurons to maintain functional axons and dendrites or by neuron death. During the past dozen years, a steadily accumulating body of evidence has indicated that soluble forms of A beta and tau work together, independently of their accumulation into plaques and tangles, to drive healthy neurons into the diseased state and that hallmark toxic properties of A beta require tau. For instance, acute neuron death, delayed neuron death following ectopic cell cycle reentry, and synaptic dysfunction are triggered by soluble, extracellular A beta species and depend on soluble, cytoplasmic tau. Therefore, A beta is upstream of tau in AD pathogenesis and triggers the conversion of tau from a normal to a toxic state, but there is also evidence that toxic tau enhances A beta toxicity via a feedback loop. Because soluble toxic aggregates of both A beta and tau can self-propagate and spread throughout the brain by prionlike mechanisms, successful therapeutic intervention for AD would benefit from detecting these species before plaques, tangles, and cognitive impairment become evident and from interfering with the destructive biochemical pathways that they initiate.
引用
收藏
页码:505 / 508
页数:4
相关论文
共 42 条
[1]
Alzheimer A, 1995, Clin Anat, V8, P429
[3]
[Anonymous], 1907, ALLGEMEINE PSYCHATRI
[4]
BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371
[5]
NEUROPATHOLOGICAL STAGING OF ALZHEIMER-RELATED CHANGES [J].
BRAAK, H ;
BRAAK, E .
ACTA NEUROPATHOLOGICA, 1991, 82 (04) :239-259
[6]
Transmission and spreading of tauopathy in transgenic mouse brain [J].
Clavaguera, Florence ;
Bolmont, Tristan ;
Crowther, R. Anthony ;
Abramowski, Dorothee ;
Frank, Stephan ;
Probst, Alphonse ;
Fraser, Graham ;
Stalder, Anna K. ;
Beibel, Martin ;
Staufenbiel, Matthias ;
Jucker, Mathias ;
Goedert, Michel ;
Tolnay, Markus .
NATURE CELL BIOLOGY, 2009, 11 (07) :909-U325
[7]
Propagation of Tau Pathology in a Model of Early Alzheimer's Disease [J].
de Calignon, Alix ;
Polydoro, Manuela ;
Suarez-Calvet, Marc ;
William, Christopher ;
Adamowicz, David H. ;
Kopeikina, Kathy J. ;
Pitstick, Rose ;
Sahara, Naruhiko ;
Ashe, Karen H. ;
Carlson, George A. ;
Spires-Jones, Tara L. ;
Hyman, Bradley T. .
NEURON, 2012, 73 (04) :685-697
[8]
PATHOLOGICAL PROTEINS TAU-64 AND TAU-69 ARE SPECIFICALLY EXPRESSED IN THE SOMATODENDRITIC DOMAIN OF THE DEGENERATING CORTICAL-NEURONS DURING ALZHEIMERS-DISEASE - DEMONSTRATION WITH A PANEL OF ANTIBODIES AGAINST TAU-PROTEINS [J].
DELACOURTE, A ;
FLAMENT, S ;
DIBE, EM ;
HUBLAU, P ;
SABLONNIERE, B ;
HEMON, B ;
SHERRER, V ;
DEFOSSEZ, A .
ACTA NEUROPATHOLOGICA, 1990, 80 (02) :111-117
[9]
Propagation of Tau Misfolding from the Outside to the Inside of a Cell [J].
Frost, Bess ;
Jacks, Rachel L. ;
Diamond, Marc I. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (19) :12845-12852
[10]
The propagation of prion-like protein inclusions in neurodegenerative diseases [J].
Goedert, Michel ;
Clavaguera, Florence ;
Tolnay, Markus .
TRENDS IN NEUROSCIENCES, 2010, 33 (07) :317-325